SCLXWScilex Holding Covs its industry peers
A metric-by-metric comparison of Scilex Holding Co against Biological Products, (No Diagnostic Substances) — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Empresa | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SCLXWEsta | $1M#9 | — | — | 0.0x#1 | -46.5%#6 | -413.8%#12 | -1143.7%#3 | — | — | 4#1 | 225.4%#1 | — |
| BCAB | — | 0.1x#5 | — | — | — | -14.6%#10 | -19768.3%#8 | — | — | — | -94.8%#11 | — |
| WINT | $3M#3 | — | — | 17.1x#4 | -88.9%#7 | 91.2%#3 | -13201.5%#7 | — | -308.7%#2 | — | -75.1%#8 | 19.4%#1 |
| ESLAW | $3M#4 | — | — | — | — | — | — | — | — | — | 5.4%#3 | — |
| SABSW | $3M#5 | 0.1x#6 | 0.0x#1 | — | -100.0%#8 | 138.9%#1 | — | 6.2%#1 | — | — | -24.9%#5 | — |
| CEROW | $3M#6 | — | — | — | — | — | — | — | — | — | 145.3%#2 | 4.9%#2 |
| SLXN | $2M#7 | 0.0x#3 | 55.3x#5 | — | — | 27.9%#8 | — | -27072.7%#4 | — | — | -98.8%#13 | — |
| CRIS | $2M#8 | 0.1x#4 | 0.5x#3 | 0.2x#2 | -13.4%#5 | 82.5%#4 | -60.5%#2 | -161.5%#3 | -87.3%#1 | — | -97.1%#12 | — |
| VIVS | $4M#2 | — | — | 27.3x#5 | -9.0%#4 | -456.4%#13 | -8768.7%#6 | — | — | — | -93.8%#10 | — |
| TVGNW | $312554#10 | — | — | — | — | -91.4%#11 | — | — | — | — | -7.7%#4 | — |
| JSPRW | $296144#11 | — | 0.2x#2 | — | — | 100.0%#2 | — | -0.0%#2 | — | — | -91.1%#9 | — |
| ABPWW | $116152#12 | 0.0x#2 | — | 0.6x#3 | 50.0%#2 | 60.0%#5 | -4618.6%#4 | — | — | — | -50.8%#6 | — |
| SLXNW | $77844#13 | 0.0x#1 | 1.8x#4 | — | — | 27.9%#8 | — | -27072.7%#4 | — | — | -63.3%#7 | — |
| ABPO | — | — | — | — | 50.0%#2 | 60.0%#5 | -4618.6%#4 | — | — | — | — | — |
| ADAPY | — | — | — | — | 195.3%#1 | 37.8%#7 | -38.6%#1 | — | — | — | — | — |
| AGMB | $415M#1 | — | — | — | — | — | — | — | — | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2836). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Table built 2026-09-20.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice